Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease

B Fonseca-Santos, MPD Gremião… - International Journal of …, 2015 - Taylor & Francis
Alzheimer's disease is a neurological disorder that results in cognitive and behavioral
impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs …

Recent trends in praziquantel nanoformulations for helminthiasis treatment

AC Mengarda, B Iles, JP F. Longo… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Infections caused by parasitic flatworms impose a considerable worldwide
health burden. Recently, World Health Organization launched its roadmap for neglected …

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

TH Marczylo, RD Verschoyle, DN Cooke… - Cancer chemotherapy …, 2007 - Springer
Purpose Curcumin, a major constituent of the spice turmeric, suppresses expression of the
enzyme cyclooxygenase 2 (Cox-2) and has cancer chemopreventive properties in rodents. It …

Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt

Y Chen, Y Lu, J Chen, J Lai, J Sun, F Hu… - International journal of …, 2009 - Elsevier
The main purpose of this study was to evaluate oral bioavailability of the poorly water-
soluble drug fenofibrate when liposomes containing a bile salt were used as oral drug …

Nanoparticles for antiparasitic drug delivery

Y Sun, D Chen, Y Pan, W Qu, H Hao, X Wang, Z Liu… - Drug Delivery, 2019 - Taylor & Francis
As an emerging novel drug carrier, nanoparticles provide a promising way for effective
treatment of parasitic diseases by overcoming the shortcomings of low bioavailability, poor …

[PDF][PDF] Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection

D Alonso, J Muñoz, J Gascón, ME Valls… - American Journal of …, 2006 - Citeseer
A single 40 mg/kg dose of praziquantel (PZQ) continues to be the standard treatment for
schistosomiasis caused by S. mansoni and S. haematobium in all clinical settings …

Lipossomas e suas aplicações terapêuticas: Estado da arte

CM Batista, CMB Carvalho… - Revista Brasileira de …, 2007 - SciELO Brasil
Lipossomas são vesículas constituídas de uma ou mais bicamadas fosfolipídicas orientadas
concentricamente em torno de um compartimento aquoso e servem como carreadores de …

Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis

A Qadeer, H Ullah, M Sohail, SZ Safi… - … in Bioengineering and …, 2022 - frontiersin.org
Schistosomiasis is one of the neglected tropical diseases that affect millions of people
worldwide. Globally, it affects economically poor countries, typically due to a lack of proper …

Nanopharmaceuticals as a solution to neglected diseases: Is it possible?

GA Islan, M Durán, ML Cacicedo, G Nakazato… - Acta tropica, 2017 - Elsevier
The study of neglected diseases has not received much attention, especially from public and
private institutions over the last years, in terms of strong support for developing treatment for …

Animais de laboratório: o camundongo

M Chorilli, DC Michelin… - Revista de Ciências …, 2007 - rcfba.fcfar.unesp.br
A experimentação animal nas pesquisas científicas tem contribuído sobremaneira para o
desenvolvimento da ciência e tecnologia, promovendo ao longo dos anos a descoberta de …